APO Research
Talk to an analyst

APO RESEARCH · REPORT

Granisetron

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Granisetron Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchGranisetron Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Granisetron Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Granisetron Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Granisetron Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Granisetron Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Granisetron market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Granisetron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Granisetron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Granisetron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Granisetron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Granisetron include Kyowa Kirin, Teva, Sandoz, Mylan, Fresenius Kabi, Wockhardt, Taro Pharmaceutical, Natco Pharma and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Granisetron market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Granisetron and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Granisetron revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Granisetron market size, projected growth trends, production technologies, key applications, and end-use industries.

Granisetron Segment by Company

Kyowa Kirin

Teva

Sandoz

Mylan

Fresenius Kabi

Wockhardt

Taro Pharmaceutical

Natco Pharma

Hikma Pharmaceuticals

Heron Therapeutics

Dr.Reddy's

Cipla

Bluepharma

Aurobindo

APOTEX

Akorn

Granisetron Segment by Type

Injection

Transdermal system

Oral

Granisetron Segment by Application

Chemotherapy

Post operative

Granisetron Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granisetron market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Granisetron and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granisetron.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Granisetron in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Granisetron industry.

Chapter 3: Detailed analysis of Granisetron companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Granisetronrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Granisetron Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Injection Table 3. Key Players of Transdermal system Table 4. Key Players of Oral Table 4. Global Granisetron Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Chemotherapy Table 6. Key Players of Post operative Table 7. Global Granisetron Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Granisetron Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Granisetron Market Share by Region (2021-2026) Table 10. Global Granisetron Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Granisetron Market Share by Region (2027-2032) Table 12. Granisetron Industry Trends Table 13. Granisetron Industry Drivers Table 14. Granisetron Industry Opportunities and Challenges Table 15. Granisetron Industry Restraints Table 16. Global Granisetron Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Granisetron Revenue Market Share by Company (2021-2026) Table 18. Global Granisetron Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Granisetron Key Company Head Office and Area Served Table 20. Global Granisetron Company, Product Type & Application Table 21. Global Granisetron Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Granisetron by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Granisetron Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Granisetron Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Granisetron Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Granisetron Revenue Market Share by Type (2021-2026) Table 28. Global Granisetron Revenue Market Share by Type (2027-2032) Table 29. Global Granisetron Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Granisetron Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Granisetron Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Granisetron Revenue Market Share by Application (2021-2026) Table 33. Global Granisetron Revenue Market Share by Application (2027-2032) Table 34. Kyowa Kirin Company Information Table 35. Kyowa Kirin Business Overview Table 36. Kyowa Kirin Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Kyowa Kirin Granisetron Product Portfolio Table 38. Kyowa Kirin Recent Development Table 39. Teva Company Information Table 40. Teva Business Overview Table 41. Teva Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Teva Granisetron Product Portfolio Table 43. Teva Recent Development Table 44. Sandoz Company Information Table 45. Sandoz Business Overview Table 46. Sandoz Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Sandoz Granisetron Product Portfolio Table 48. Sandoz Recent Development Table 49. Mylan Company Information Table 50. Mylan Business Overview Table 51. Mylan Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Mylan Granisetron Product Portfolio Table 53. Mylan Recent Development Table 54. Fresenius Kabi Company Information Table 55. Fresenius Kabi Business Overview Table 56. Fresenius Kabi Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Fresenius Kabi Granisetron Product Portfolio Table 58. Fresenius Kabi Recent Development Table 59. Wockhardt Company Information Table 60. Wockhardt Business Overview Table 61. Wockhardt Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Wockhardt Granisetron Product Portfolio Table 63. Wockhardt Recent Development Table 64. Taro Pharmaceutical Company Information Table 65. Taro Pharmaceutical Business Overview Table 66. Taro Pharmaceutical Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Taro Pharmaceutical Granisetron Product Portfolio Table 68. Taro Pharmaceutical Recent Development Table 69. Natco Pharma Company Information Table 70. Natco Pharma Business Overview Table 71. Natco Pharma Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Natco Pharma Granisetron Product Portfolio Table 73. Natco Pharma Recent Development Table 74. Hikma Pharmaceuticals Company Information Table 75. Hikma Pharmaceuticals Business Overview Table 76. Hikma Pharmaceuticals Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Hikma Pharmaceuticals Granisetron Product Portfolio Table 78. Hikma Pharmaceuticals Recent Development Table 79. Heron Therapeutics Company Information Table 80. Heron Therapeutics Business Overview Table 81. Heron Therapeutics Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Heron Therapeutics Granisetron Product Portfolio Table 83. Heron Therapeutics Recent Development Table 84. Dr.Reddy's Company Information Table 85. Dr.Reddy's Business Overview Table 86. Dr.Reddy's Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Dr.Reddy's Granisetron Product Portfolio Table 88. Dr.Reddy's Recent Development Table 89. Cipla Company Information Table 90. Cipla Business Overview Table 91. Cipla Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Cipla Granisetron Product Portfolio Table 93. Cipla Recent Development Table 94. Bluepharma Company Information Table 95. Bluepharma Business Overview Table 96. Bluepharma Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Bluepharma Granisetron Product Portfolio Table 98. Bluepharma Recent Development Table 99. Aurobindo Company Information Table 100. Aurobindo Business Overview Table 101. Aurobindo Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Aurobindo Granisetron Product Portfolio Table 103. Aurobindo Recent Development Table 104. APOTEX Company Information Table 105. APOTEX Business Overview Table 106. APOTEX Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. APOTEX Granisetron Product Portfolio Table 108. APOTEX Recent Development Table 109. Akorn Company Information Table 110. Akorn Business Overview Table 111. Akorn Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Akorn Granisetron Product Portfolio Table 113. Akorn Recent Development Table 114. North America Granisetron Market Size by Type (2021-2026) & (US$ Million) Table 115. North America Granisetron Market Size by Type (2027-2032) & (US$ Million) Table 116. North America Granisetron Market Size by Application (2021-2026) & (US$ Million) Table 117. North America Granisetron Market Size by Application (2027-2032) & (US$ Million) Table 118. North America Granisetron Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Granisetron Market Size by Country (2021-2026) Table 120. North America Granisetron Market Size by Country (2027-2032) Table 121. Europe Granisetron Market Size by Type (2021-2026) & (US$ Million) Table 122. Europe Granisetron Market Size by Type (2027-2032) & (US$ Million) Table 123. Europe Granisetron Market Size by Application (2021-2026) & (US$ Million) Table 124. Europe Granisetron Market Size by Application (2027-2032) & (US$ Million) Table 125. Europe Granisetron Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe Granisetron Market Size by Country (2021-2026) Table 127. Europe Granisetron Market Size by Country (2027-2032) Table 128. China Granisetron Market Size by Type (2021-2026) & (US$ Million) Table 129. China Granisetron Market Size by Type (2027-2032) & (US$ Million) Table 130. China Granisetron Market Size by Application (2021-2026) & (US$ Million) Table 131. China Granisetron Market Size by Application (2027-2032) & (US$ Million) Table 132. Asia Granisetron Market Size by Type (2021-2026) & (US$ Million) Table 133. Asia Granisetron Market Size by Type (2027-2032) & (US$ Million) Table 134. Asia Granisetron Market Size by Application (2021-2026) & (US$ Million) Table 135. Asia Granisetron Market Size by Application (2027-2032) & (US$ Million) Table 136. Asia Granisetron Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Asia Granisetron Market Size by Country (2021-2026) Table 138. Asia Granisetron Market Size by Country (2027-2032) Table 139. South America, Middle East & Africa Granisetron Market Size by Type (2021-2026) & (US$ Million) Table 140. South America, Middle East & Africa Granisetron Market Size by Type (2027-2032) & (US$ Million) Table 141. South America, Middle East & Africa Granisetron Market Size by Application (2021-2026) & (US$ Million) Table 142. South America, Middle East & Africa Granisetron Market Size by Application (2027-2032) & (US$ Million) Table 143. South America, Middle East & Africa Granisetron Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. South America, Middle East & Africa Granisetron Market Size by Country (2021-2026) Table 145. South America, Middle East & Africa Granisetron Market Size by Country (2027-2032) Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Granisetron Product Image Figure 2. Global Granisetron Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Granisetron Market Share by Type: 2025 VS 2032 Figure 4. Injection Image Figure 5. Transdermal system Image Figure 6. Oral Image Figure 7. Global Granisetron Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Granisetron Market Share by Application: 2025 VS 2032 Figure 9. Chemotherapy Image Figure 10. Post operative Image Figure 11. Global Granisetron Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Granisetron Market Size (2021-2032) & (US$ Million) Figure 13. Global Granisetron Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Granisetron Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Granisetron Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Granisetron Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Granisetron Revenue Market Share by Type (2021-2032) Figure 20. Global Granisetron Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Granisetron Revenue Market Share by Application (2021-2032) Figure 22. North America Granisetron Market Size (2021-2032) & (US$ Million) Figure 23. North America Granisetron Market Share by Type (2021-2032) Figure 24. North America Granisetron Market Share by Application (2021-2032) Figure 25. North America Granisetron Market Share by Country (2021-2032) Figure 26. United States Granisetron Market Size (2021-2032) & (US$ Million) Figure 27. Canada Granisetron Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Granisetron Market Size (2021-2032) & (US$ Million) Figure 29. Europe Granisetron Market Size (2021-2032) & (US$ Million) Figure 30. Europe Granisetron Market Share by Type (2021-2032) Figure 31. Europe Granisetron Market Share by Application (2021-2032) Figure 32. Europe Granisetron Market Share by Country (2021-2032) Figure 33. Germany Granisetron Market Size (2021-2032) & (US$ Million) Figure 34. France Granisetron Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Granisetron Market Size (2021-2032) & (US$ Million) Figure 36. Italy Granisetron Market Size (2021-2032) & (US$ Million) Figure 37. Russia Granisetron Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Granisetron Market Size (2021-2032) & (US$ Million) Figure 39. China Granisetron Market Size (2021-2032) & (US$ Million) Figure 40. China Granisetron Market Share by Type (2021-2032) Figure 41. China Granisetron Market Share by Application (2021-2032) Figure 42. Asia Granisetron Market Size (2021-2032) & (US$ Million) Figure 43. Asia Granisetron Market Share by Type (2021-2032) Figure 44. Asia Granisetron Market Share by Application (2021-2032) Figure 45. Asia Granisetron Market Share by Country (2021-2032) Figure 46. Japan Granisetron Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Granisetron Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Granisetron Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Granisetron Market Size (2021-2032) & (US$ Million) Figure 50. India Granisetron Market Size (2021-2032) & (US$ Million) Figure 51. Australia Granisetron Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Granisetron Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Granisetron Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Granisetron Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Granisetron Market Share by Country (2021-2032) Figure 56. Brazil Granisetron Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Granisetron Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Granisetron Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Granisetron Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Granisetron Market Size (2021-2032) & (US$ Million) Figure 61. UAE Granisetron Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Granisetron Market Size (2021-2032) & (US$ Million) Figure 63. Chile Granisetron Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Transdermal system
  • Oral
Applications
  • Chemotherapy
  • Post operative
Companies covered
  • Kyowa Kirin
  • Teva
  • Sandoz
  • Mylan
  • Fresenius Kabi
  • Wockhardt
  • Taro Pharmaceutical
  • Natco Pharma
  • Hikma Pharmaceuticals
  • Heron Therapeutics
  • Dr.Reddy's
  • Cipla
  • Bluepharma
  • Aurobindo
  • APOTEX
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Granisetron Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Transdermal system
  6. 1.2.4 Oral
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Granisetron Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Chemotherapy
  10. 1.3.3 Post operative
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Granisetron Growth Trends by Region
  13. 1.5.1 Global Granisetron Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Granisetron Market Size by Region (2021-2026)
  15. 1.5.3 Granisetron Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Granisetron Market Dynamics
  1. 2.1 Granisetron Industry Trends
  2. 2.2 Granisetron Industry Drivers
  3. 2.3 Granisetron Industry Opportunities and Challenges
  4. 2.4 Granisetron Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Granisetron Revenue by Company (2021-2026)
  2. 3.2 Global Granisetron Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Granisetron Key Company Head office and Area Served
  4. 3.4 Global Granisetron Company, Product Type & Application
  5. 3.5 Global Granisetron Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Granisetron Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Granisetron Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Granisetron Tier 1, Tier 2, and Tier 3
4 Granisetron Market by Type
  1. 4.1 Global Granisetron Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Granisetron Market Size by Type (2021-2032)
  3. 4.3 Global Granisetron Market Size Share by Type (2021-2032)
5 Granisetron Market by Application
  1. 5.1 Global Granisetron Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Granisetron Market Size by Application (2021-2032)
  3. 5.3 Global Granisetron Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Kyowa Kirin
  2. 6.1.1 Kyowa Kirin Company Information
  3. 6.1.2 Kyowa Kirin Business Overview
  4. 6.1.3 Kyowa Kirin Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Kyowa Kirin Granisetron Product Portfolio
  6. 6.1.5 Kyowa Kirin Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Teva Granisetron Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sandoz
  14. 6.3.1 Sandoz Company Information
  15. 6.3.2 Sandoz Business Overview
  16. 6.3.3 Sandoz Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sandoz Granisetron Product Portfolio
  18. 6.3.5 Sandoz Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Mylan Granisetron Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Fresenius Kabi
  26. 6.5.1 Fresenius Kabi Company Information
  27. 6.5.2 Fresenius Kabi Business Overview
  28. 6.5.3 Fresenius Kabi Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Fresenius Kabi Granisetron Product Portfolio
  30. 6.5.5 Fresenius Kabi Recent Developments
  31. 6.6 Wockhardt
  32. 6.6.1 Wockhardt Company Information
  33. 6.6.2 Wockhardt Business Overview
  34. 6.6.3 Wockhardt Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Wockhardt Granisetron Product Portfolio
  36. 6.6.5 Wockhardt Recent Developments
  37. 6.7 Taro Pharmaceutical
  38. 6.7.1 Taro Pharmaceutical Company Information
  39. 6.7.2 Taro Pharmaceutical Business Overview
  40. 6.7.3 Taro Pharmaceutical Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Taro Pharmaceutical Granisetron Product Portfolio
  42. 6.7.5 Taro Pharmaceutical Recent Developments
  43. 6.8 Natco Pharma
  44. 6.8.1 Natco Pharma Company Information
  45. 6.8.2 Natco Pharma Business Overview
  46. 6.8.3 Natco Pharma Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Natco Pharma Granisetron Product Portfolio
  48. 6.8.5 Natco Pharma Recent Developments
  49. 6.9 Hikma Pharmaceuticals
  50. 6.9.1 Hikma Pharmaceuticals Company Information
  51. 6.9.2 Hikma Pharmaceuticals Business Overview
  52. 6.9.3 Hikma Pharmaceuticals Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Hikma Pharmaceuticals Granisetron Product Portfolio
  54. 6.9.5 Hikma Pharmaceuticals Recent Developments
  55. 6.10 Heron Therapeutics
  56. 6.10.1 Heron Therapeutics Company Information
  57. 6.10.2 Heron Therapeutics Business Overview
  58. 6.10.3 Heron Therapeutics Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Heron Therapeutics Granisetron Product Portfolio
  60. 6.10.5 Heron Therapeutics Recent Developments
  61. 6.11 Dr.Reddy's
  62. 6.11.1 Dr.Reddy's Company Information
  63. 6.11.2 Dr.Reddy's Business Overview
  64. 6.11.3 Dr.Reddy's Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Dr.Reddy's Granisetron Product Portfolio
  66. 6.11.5 Dr.Reddy's Recent Developments
  67. 6.12 Cipla
  68. 6.12.1 Cipla Company Information
  69. 6.12.2 Cipla Business Overview
  70. 6.12.3 Cipla Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Cipla Granisetron Product Portfolio
  72. 6.12.5 Cipla Recent Developments
  73. 6.13 Bluepharma
  74. 6.13.1 Bluepharma Company Information
  75. 6.13.2 Bluepharma Business Overview
  76. 6.13.3 Bluepharma Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Bluepharma Granisetron Product Portfolio
  78. 6.13.5 Bluepharma Recent Developments
  79. 6.14 Aurobindo
  80. 6.14.1 Aurobindo Company Information
  81. 6.14.2 Aurobindo Business Overview
  82. 6.14.3 Aurobindo Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Aurobindo Granisetron Product Portfolio
  84. 6.14.5 Aurobindo Recent Developments
  85. 6.15 APOTEX
  86. 6.15.1 APOTEX Company Information
  87. 6.15.2 APOTEX Business Overview
  88. 6.15.3 APOTEX Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 APOTEX Granisetron Product Portfolio
  90. 6.15.5 APOTEX Recent Developments
  91. 6.16 Akorn
  92. 6.16.1 Akorn Company Information
  93. 6.16.2 Akorn Business Overview
  94. 6.16.3 Akorn Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Akorn Granisetron Product Portfolio
  96. 6.16.5 Akorn Recent Developments
7 North America
  1. 7.1 North America Granisetron Market Size (2021-2032)
  2. 7.2 North America Granisetron Market Size by Type
  3. 7.2.1 North America Granisetron Market Size by Type (2021-2026)
  4. 7.2.2 North America Granisetron Market Size by Type (2027-2032)
  5. 7.2.3 North America Granisetron Market Share by Type (2021-2032)
  6. 7.3 North America Granisetron Market Size by Application
  7. 7.3.1 North America Granisetron Market Size by Application (2021-2026)
  8. 7.3.2 North America Granisetron Market Size by Application (2027-2032)
  9. 7.3.3 North America Granisetron Market Share by Application (2021-2032)
  10. 7.4 North America Granisetron Market Size by Country
  11. 7.4.1 North America Granisetron Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Granisetron Market Size by Country (2021-2026)
  13. 7.4.3 North America Granisetron Market Size by Country (2027-2032)
  14. 7.4.4 North America Granisetron Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Granisetron Market Size (2021-2032)
  2. 8.2 Europe Granisetron Market Size by Type
  3. 8.2.1 Europe Granisetron Market Size by Type (2021-2026)
  4. 8.2.2 Europe Granisetron Market Size by Type (2027-2032)
  5. 8.2.3 Europe Granisetron Market Share by Type (2021-2032)
  6. 8.3 Europe Granisetron Market Size by Application
  7. 8.3.1 Europe Granisetron Market Size by Application (2021-2026)
  8. 8.3.2 Europe Granisetron Market Size by Application (2027-2032)
  9. 8.3.3 Europe Granisetron Market Share by Application (2021-2032)
  10. 8.4 Europe Granisetron Market Size by Country
  11. 8.4.1 Europe Granisetron Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Granisetron Market Size by Country (2021-2026)
  13. 8.4.3 Europe Granisetron Market Size by Country (2027-2032)
  14. 8.4.4 Europe Granisetron Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Granisetron Market Size (2021-2032)
  2. 9.2 China Granisetron Market Size by Type
  3. 9.2.1 China Granisetron Market Size by Type (2021-2026)
  4. 9.2.2 China Granisetron Market Size by Type (2027-2032)
  5. 9.2.3 China Granisetron Market Share by Type (2021-2032)
  6. 9.3 China Granisetron Market Size by Application
  7. 9.3.1 China Granisetron Market Size by Application (2021-2026)
  8. 9.3.2 China Granisetron Market Size by Application (2027-2032)
  9. 9.3.3 China Granisetron Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Granisetron Market Size (2021-2032)
  2. 10.2 Asia Granisetron Market Size by Type
  3. 10.2.1 Asia Granisetron Market Size by Type (2021-2026)
  4. 10.2.2 Asia Granisetron Market Size by Type (2027-2032)
  5. 10.2.3 Asia Granisetron Market Share by Type (2021-2032)
  6. 10.3 Asia Granisetron Market Size by Application
  7. 10.3.1 Asia Granisetron Market Size by Application (2021-2026)
  8. 10.3.2 Asia Granisetron Market Size by Application (2027-2032)
  9. 10.3.3 Asia Granisetron Market Share by Application (2021-2032)
  10. 10.4 Asia Granisetron Market Size by Country
  11. 10.4.1 Asia Granisetron Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Granisetron Market Size by Country (2021-2026)
  13. 10.4.3 Asia Granisetron Market Size by Country (2027-2032)
  14. 10.4.4 Asia Granisetron Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Granisetron Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Granisetron Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Granisetron Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Granisetron Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Granisetron Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Granisetron Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Granisetron Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Granisetron Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Granisetron Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Granisetron Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Granisetron Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Granisetron Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Granisetron Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Granisetron Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst